NKGN

PINK NKGen Biotech Inc.
Oct 18, 2026 · 3:43 PM ET EOD Market Closed

$0.0110 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0110, and at the day’s high of $0.0110

YTD change
-78.00%
vs 20-day SMA
+79.74%
vs 200-day SMA
-82.54%

Price ranges

Previous day
$0.0110 $0.0110
open $0.0110 close $0.0110
+$0.0000 (+0.00%)
Today
$0.0110 $0.0110
$0.0110
Past week
$0.0021 $0.0120
from $0.0120 now $0.0110
-$0.0010 (-8.33%)
Past month
$0.0020 $0.0800
from $0.0051 now $0.0110
+$0.0059 (+115.69%)
This year
$0.0010 $0.2000
from $0.0500 now $0.0110
-$0.0390 (-78.00%)

Price & Performance

-0.05 (-81.67%) / 6M

$-0.0098$0.0474$0.1046$0.1618Apr 20Jul 7Oct 16

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 99.8% away from all-time highs of $6.7000
  • NKGN is down 78% since the beginning of the year
  • NKGN is up 450% over the past 12 months
  • NKGN is up 116% over the past 1 month
  • 1% of all NKGN investors are betting against NKGN

NKGN reads n/a: price sits above one of the two key moving averages, the 12-month move is +0.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0404
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $39.3M
Beta 1.84

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$29.0K
Debt$38.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $1.4M

NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $33.35 +2.30%
ARGX argenx SE Sponsored ADR $819.14 -3.21%
ONC BeOne Medicines Ltd. Sponsored ADR $369.06 -1.34%
WXIBF Wuxi Biologics (Cayman) Inc. $6.36 +2.66%
INCY Incyte Corporation $113.07 -0.18%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.